References - Brain/Cognitive Protocol

1.  Bai DL, Tang XC, He XC.  "Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease." Curr Med Chem. 2000 Mar;7(3):355-74.

2.  Wang R, Yan H, Tang XC.  "Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine." Acta Pharmacol Sin. 2006 Jan;27(1):1-26.

3. Veerendra Kumar MH, Gupta YK. "Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats." Clin Exp Pharmacol Physiol. 2003 May-Jun;30(5-6):336-42.

4. DeFeudis FV, Drieu K.  "Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications."  Curr Drug Targets. 2000 Jul;1(1):25-58.

5. Arwert LI, Deijen JB, Drent ML.  "Effects of an oral mixture containing glycine, glutamine and niacin on memory, GH and IGF-I secretion in middle-aged and elderly subjects." Nutr Neurosci. 2003 Oct;6(5):269-75.

6. Zangara A.  "The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease." Pharmacol Biochem Behav. 2003 Jun;75(3):675-86.

7. Toffano, G.  in Lecithin:  Technological, Biological, and Therapeutic Agents, ed. I Hanin and G. B. Ansell.  (New York:  Plenum Press, 1987) 137-146.

8. Kennedy DO, Haskell CF, Mauri PL, Scholey.  "Acute cognitive effects of standardised Ginkgo biloba extract complexed with phosphatidylserine." Hum Psychopharmacol. 2007 Apr 25;22(4):199-210.

9. Rebouche CJ.  "Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism."  Ann N Y Acad Sci. 2004 Nov;1033:30-41.

10. White HL, Scates PW.  "Acetyl-L-carnitine as a precursor of acetylcholine."  Neurochem Res. 1990 Jun;15(6):597-601.

11. Pettegrew JW, Levine J, McClure RJ. "Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression." Mol Psychiatry. 2000 Nov;5(6):616-32.

12. Mondillo S, Faglia S, D'Aprile N, et al.  "[Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine]"  Clin Ter. 1995 Dec;146(12):769-74. Italian.

13. “Possible Interactions with: Carnitine (L-Carnitine)” on the University of Maryland Medical Center www.umm.edu/altmed/ConsSupplements/Interactions/CarnitineLCarnitinecs.html